EpiPen maker Mylan will sell a cheaper version of its life-saving allergy treatment

From the Verge:

The maker of the EpiPen announced today it will start selling a generic of its live-saving allergy treatment for $300 for a two-pack, according to Reuters. Mylan NV has been highly criticized recently for spiking the price of its drug to more than $600 from $100 in 2008.

The EpiPen, which is sold in two-packs due to federal guidelines, delivers a hormone called epinephrine that ends potentially life-threatening allergy attacks. There’s actually less than $1 worth of epinephrine in each EpiPen.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: